About this trial
This quasi-experimental laboratory study aims to describe and compare the multidimensional experience of dyspnea at rest and during exertion in patients with chronic obstructive pulmonary disease (COPD) and healthy controls. The study integrates neurophysiological, somatosensory, and psychological assessments, including prefrontal cortex activity (fNIRS), quantitative sensory testing (QST), and immersive virtual reality (VR) scenarios.
Additionally, the study evaluates the modulation of dyspnea perception through expectation mechanisms and placebo intervention using high-flow nasal cannula (HFNC). The ultimate goal is to better understand the multidimensional and neurocognitive mechanisms underlying dyspnea.
Eligibility criteria
Qualifiers
Diagnosed COPD (FEV1/FVC < 0.7 post-bronchodilator)
GOLD stage 2-4
Clinically stable
Signed informed consent
Disqualifiers
Severe cardiac, neurological, or psychiatric disease
Other respiratory diseases
Recent exacerbation
Use of ventilatory support (except CPAP)
Trial design
Treatments tested in this trial
- Induced Dyspnea via Inspiratory Muscle Loading
- Virtual Reality Sensory Immersion
- Placebo and Active Conditions
Treatment groups
Sponsors and collaborators
University of Deusto
Lead sponsor
Osakidetza
Collaborator